US Stock MarketDetailed Quotes

Scinai Immunotherapeutics (SCNI)

Watchlist
  • 0.8650
  • -0.0442-4.86%
Close Jan 16 16:00 ET
  • 0.8700
  • +0.0050+0.58%
Post 19:47 ET
3.00MMarket Cap0.22P/E (TTM)

Scinai Immunotherapeutics (SCNI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.48%-6.34M
12.16%-1.08M
8.28%-2.04M
68.34%-1.76M
-282.98%-1.46M
-29.14%-9.38M
-106.58%-1.23M
-16.82%-2.22M
-85.28%-5.55M
65.43%-382K
Net income from continuing operations
173.78%4.8M
4.29%-2.23M
270.36%11.51M
38.28%-2.32M
38.58%-2.16M
-12.15%-6.5M
54.46%-2.33M
-34.97%3.11M
-1.63%-3.76M
-42.02%-3.52M
Operating gains losses
97.75%-93K
--0
--0
--3K
---96K
---4.14M
---216K
---591K
----
----
Depreciation and amortization
220.82%1.65M
494.05%499K
243.45%498K
237.41%496K
13.04%156K
-8.54%514K
-54.35%84K
46.46%145K
-34.40%147K
2.99%138K
Other non cash items
-3,461.85%-13.48M
-103.12%-24K
-196.55%-13.91M
-95.13%226K
169.66%225K
110.27%401K
-73.12%770K
32.50%-4.69M
1,308.71%4.64M
-236.29%-323K
Change In working capital
114.07%112K
3,292.86%475K
34.43%-280K
60.75%-303K
-43.44%220K
-393.73%-796K
-98.70%14K
-158.79%-427K
-256.66%-772K
-24.32%389K
-Change in receivables
148.62%141K
173.08%152K
97.78%-2K
-19.70%-158K
6.43%149K
-307.14%-290K
-572.73%-208K
-373.68%-90K
-2,595.95%-132K
13.82%140K
-Change in payables and accrued expense
100.20%1K
58.30%353K
17.26%-278K
77.43%-144K
-73.08%70K
-466.42%-491K
-78.45%223K
-128.57%-336K
40.85%-638K
-33.33%260K
-Change in other current assets
560.47%284K
-33.33%38K
2,750.00%57K
5,600.00%114K
516.67%75K
-71.90%43K
-65.03%57K
--2K
--2K
-128.57%-18K
-Change in other current liabilities
-441.38%-314K
-17.24%-68K
-1,800.00%-57K
-2,775.00%-115K
-1,157.14%-74K
62.82%-58K
65.06%-58K
-400.00%-3K
-100.25%-4K
111.29%7K
Cash from discontinued investing activities
Operating cash flow
32.48%-6.34M
12.16%-1.08M
8.28%-2.04M
38.87%-1.76M
52.17%-1.46M
-29.14%-9.38M
-106.58%-1.23M
-16.82%-2.22M
4.04%-2.88M
-176.83%-3.06M
Investing cash flow
Cash flow from continuing investing activities
98.12%-12K
0
80.00%-4K
98.41%-6K
66.67%-2K
23.80%-637K
13.33%-234K
75.00%-20K
-1,458.29%-377K
98.85%-6K
Net PPE purchase and sale
98.12%-12K
--0
80.00%-4K
98.41%-6K
66.67%-2K
23.80%-637K
13.33%-234K
75.00%-20K
-2,874.92%-377K
98.85%-6K
Cash from discontinued investing activities
Investing cash flow
98.12%-12K
--0
80.00%-4K
98.41%-6K
66.67%-2K
23.80%-637K
13.33%-234K
75.00%-20K
-1,458.29%-377K
98.85%-6K
Financing cash flow
Cash flow from continuing financing activities
216.85%3.44M
2M
-99.26%8K
12K
1.42M
-83.97%1.09M
0
1.09M
0
0
Net common stock issuance
1,338.85%2M
----
----
----
----
-85.09%139K
----
----
----
----
Proceeds from stock option exercised by employees
52.16%1.44M
--0
-99.26%8K
--12K
--1.42M
-83.80%947K
-102.38%-139K
--1.09M
--0
--0
Cash from discontinued financing activities
Financing cash flow
216.85%3.44M
--2M
-99.26%8K
--12K
--1.42M
-83.97%1.09M
--0
--1.09M
--0
--0
Net cash flow
Beginning cash position
-64.76%5.01M
-81.97%1.17M
-57.89%3.21M
-54.55%4.97M
-64.76%5.01M
-18.85%14.22M
-23.24%6.48M
-33.19%7.63M
-22.40%10.93M
-18.85%14.22M
Current changes in cash
67.47%-2.91M
163.29%924K
-86.58%-2.16M
49.86%-1.63M
98.56%-44K
-574.19%-8.93M
-124.66%-1.46M
41.93%-1.16M
-3.07%-3.25M
-88.50%-3.07M
Effect of exchange rate changes
96.69%-9K
114.29%2K
1,471.43%110K
-195.12%-121K
--0
86.24%-272K
90.73%-14K
100.71%7K
-109.06%-41K
37.60%-224K
End cash Position
-58.18%2.1M
-58.18%2.1M
-81.97%1.17M
-57.89%3.21M
-54.55%4.97M
-64.76%5.01M
-64.76%5.01M
-23.24%6.48M
-32.91%7.63M
-29.65%10.93M
Free cash flow
36.65%-6.35M
26.25%-1.08M
8.92%-2.04M
45.77%-1.76M
52.20%-1.47M
-23.68%-10.02M
-69.06%-1.46M
-13.12%-2.24M
-8.08%-3.25M
-88.50%-3.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.48%-6.34M12.16%-1.08M8.28%-2.04M68.34%-1.76M-282.98%-1.46M-29.14%-9.38M-106.58%-1.23M-16.82%-2.22M-85.28%-5.55M65.43%-382K
Net income from continuing operations 173.78%4.8M4.29%-2.23M270.36%11.51M38.28%-2.32M38.58%-2.16M-12.15%-6.5M54.46%-2.33M-34.97%3.11M-1.63%-3.76M-42.02%-3.52M
Operating gains losses 97.75%-93K--0--0--3K---96K---4.14M---216K---591K--------
Depreciation and amortization 220.82%1.65M494.05%499K243.45%498K237.41%496K13.04%156K-8.54%514K-54.35%84K46.46%145K-34.40%147K2.99%138K
Other non cash items -3,461.85%-13.48M-103.12%-24K-196.55%-13.91M-95.13%226K169.66%225K110.27%401K-73.12%770K32.50%-4.69M1,308.71%4.64M-236.29%-323K
Change In working capital 114.07%112K3,292.86%475K34.43%-280K60.75%-303K-43.44%220K-393.73%-796K-98.70%14K-158.79%-427K-256.66%-772K-24.32%389K
-Change in receivables 148.62%141K173.08%152K97.78%-2K-19.70%-158K6.43%149K-307.14%-290K-572.73%-208K-373.68%-90K-2,595.95%-132K13.82%140K
-Change in payables and accrued expense 100.20%1K58.30%353K17.26%-278K77.43%-144K-73.08%70K-466.42%-491K-78.45%223K-128.57%-336K40.85%-638K-33.33%260K
-Change in other current assets 560.47%284K-33.33%38K2,750.00%57K5,600.00%114K516.67%75K-71.90%43K-65.03%57K--2K--2K-128.57%-18K
-Change in other current liabilities -441.38%-314K-17.24%-68K-1,800.00%-57K-2,775.00%-115K-1,157.14%-74K62.82%-58K65.06%-58K-400.00%-3K-100.25%-4K111.29%7K
Cash from discontinued investing activities
Operating cash flow 32.48%-6.34M12.16%-1.08M8.28%-2.04M38.87%-1.76M52.17%-1.46M-29.14%-9.38M-106.58%-1.23M-16.82%-2.22M4.04%-2.88M-176.83%-3.06M
Investing cash flow
Cash flow from continuing investing activities 98.12%-12K080.00%-4K98.41%-6K66.67%-2K23.80%-637K13.33%-234K75.00%-20K-1,458.29%-377K98.85%-6K
Net PPE purchase and sale 98.12%-12K--080.00%-4K98.41%-6K66.67%-2K23.80%-637K13.33%-234K75.00%-20K-2,874.92%-377K98.85%-6K
Cash from discontinued investing activities
Investing cash flow 98.12%-12K--080.00%-4K98.41%-6K66.67%-2K23.80%-637K13.33%-234K75.00%-20K-1,458.29%-377K98.85%-6K
Financing cash flow
Cash flow from continuing financing activities 216.85%3.44M2M-99.26%8K12K1.42M-83.97%1.09M01.09M00
Net common stock issuance 1,338.85%2M-----------------85.09%139K----------------
Proceeds from stock option exercised by employees 52.16%1.44M--0-99.26%8K--12K--1.42M-83.80%947K-102.38%-139K--1.09M--0--0
Cash from discontinued financing activities
Financing cash flow 216.85%3.44M--2M-99.26%8K--12K--1.42M-83.97%1.09M--0--1.09M--0--0
Net cash flow
Beginning cash position -64.76%5.01M-81.97%1.17M-57.89%3.21M-54.55%4.97M-64.76%5.01M-18.85%14.22M-23.24%6.48M-33.19%7.63M-22.40%10.93M-18.85%14.22M
Current changes in cash 67.47%-2.91M163.29%924K-86.58%-2.16M49.86%-1.63M98.56%-44K-574.19%-8.93M-124.66%-1.46M41.93%-1.16M-3.07%-3.25M-88.50%-3.07M
Effect of exchange rate changes 96.69%-9K114.29%2K1,471.43%110K-195.12%-121K--086.24%-272K90.73%-14K100.71%7K-109.06%-41K37.60%-224K
End cash Position -58.18%2.1M-58.18%2.1M-81.97%1.17M-57.89%3.21M-54.55%4.97M-64.76%5.01M-64.76%5.01M-23.24%6.48M-32.91%7.63M-29.65%10.93M
Free cash flow 36.65%-6.35M26.25%-1.08M8.92%-2.04M45.77%-1.76M52.20%-1.47M-23.68%-10.02M-69.06%-1.46M-13.12%-2.24M-8.08%-3.25M-88.50%-3.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More